Shoaib Khan-Organic Chemistry-Young Scientist Award

Dr. Shoaib Khan - Organic Chemistry - Young Scientist Award

Doctorate at University of Science and Technology, Pakistan 

Author Profile

Scopus

Google Scholar

Early Academic Pursuits

Dr. Shoaib Khan's academic journey began in Abbottabad, where he displayed a keen interest in the sciences from an early age. Born on March 7, 1991, he completed his Secondary School Certificate (SSC) in Science in 2007 from the Board of Intermediate and Secondary Education (BISE), Abbottabad. His passion for science led him to pursue a Pre-Medical track in his Higher Secondary School Certificate (F.Sc), which he completed in 2009 from the same board. Dr. Khan's foundational education in the natural sciences set the stage for his future academic and professional achievements. Following his early education, Dr. Khan enrolled at Hazara University in Mansehra, where he obtained his Bachelor of Science (B.Sc) degree in 2012 with a focus on Botany, Zoology, and Chemistry. His academic prowess was further demonstrated through his Master's degree (M.Sc) in Organic Chemistry, completed in 2014 from the same institution.

Professional Endeavors

Dr. Shoaib Khan's professional career is marked by a blend of teaching and research. Currently, he serves as a Lecturer at the Abbottabad University of Science and Technology (AUST) in Khyber Pakhtunkhwa, Pakistan, a position he holds with the rank of BPS-18. His teaching philosophy is centered around fostering a lifelong love of learning in his students through dynamic and enthusiastic instruction. Dr. Khan integrates his extensive knowledge of organic chemistry with his proficiency in computer systems management to provide a modern and comprehensive educational experience. In addition to his teaching responsibilities, Dr. Khan is an expert in organic synthesis and computational studies. His professional qualifications include a Bachelor of Education (B.Ed) obtained in 2015 and a Master of Education (M.Ed) earned in 2019, both from Allama Iqbal Open University in Islamabad. These qualifications highlight his commitment to advancing his pedagogical skills and his dedication to educational excellence.

Contributions and Research Focus On Organic Chemistry

Dr. Shoaib Khan's research contributions are significant, particularly in the field of organic chemistry. His Ph.D. research focused on the "Design, Synthesis and Biological Evaluation of Benzimidazole Bearing Thiazolidinone, Thiazole, and Benzoxazole-Sulphonamide Derivatives." This work underscores his expertise in designing and synthesizing complex organic compounds with potential biological applications. Additionally, his M.Phil. research titled "Synthesis and Application of Silver-Oxindole Analogues Nanoconjugates" reflects his innovative approach to applying organic compounds in nanotechnology. Throughout his career, Dr. Khan has supervised 24 students and co-supervised 2 students, demonstrating his role in mentoring the next generation of chemists. As an external examiner, he has evaluated the work of 10 students, contributing to the academic rigor and standards of the institutions he is affiliated with.

Accolades and Recognition

Dr. Shoaib Khan's contributions to the field of organic chemistry have not gone unnoticed. His work has earned him a notable impact factor of 275.42, a testament to the significance and influence of his research publications. This metric reflects the high citation rates of his work, indicating its importance and relevance in the scientific community.

Impact and Influence

The impact of Dr. Khan's work extends beyond his immediate academic environment. His research on benzimidazole derivatives and silver-oxindole nanoconjugates has potential applications in pharmaceuticals and nanotechnology, fields that are critical to advancing medical and technological innovations. By bridging the gap between organic chemistry and practical applications, Dr. Khan has positioned himself as a pivotal figure in translating scientific research into real-world solutions.

Legacy and Future Contributions

Looking forward, Dr. Khan's legacy is one of dedication to education, research, and innovation. His commitment to nurturing a love of knowledge in his students ensures that his influence will persist through the accomplishments of those he has mentored. Dr. Khan is poised to continue making significant contributions to the field of organic chemistry, with ongoing research that promises to push the boundaries of what is possible in the synthesis and application of organic compounds. In summary, Dr. Shoaib Khan's career is a testament to his unwavering dedication to science and education. His journey from a young student in Abbottabad to a distinguished lecturer and researcher is marked by numerous achievements and a profound impact on the field of organic chemistry. As he continues to inspire and innovate, Dr. Khan's contributions will undoubtedly leave a lasting legacy in both academia and industry.

Citations

  • Citations     645
  • h-index          16
  • i10-index        25

Notable Publication

Investigation of novel benzimidazole-based indole/thiazole hybrids derivatives as effective anti-diabetics and anti-alzheimer's agents: Structure-activity relationship insight, in vitro and in silico approaches. 2024

Identification of in vitro α-glucosidase and urease inhibitory effect, and in silico studies of Naproxen-derived 1,3,4-oxadiazole-based Schiff-base derivatives.2024

Benzothiazole based sulfonamide scaffolds as active inhibitors of alpha-Amylase and alpha-glucosidase; synthesis, structure confirmation, In Silico molecular docking and ADME analysis.2024

New benzimidazole based Schiff bases as potent anti-alzheimer agents: Synthesis, bio-evaluation and molecular docking study.2024

In vitro β–glucuronidase and in silico molecular docking studies of thiazole-fused-thiadiazole derivatives prepared through molecular-iodine promoted [3+2] oxidative cyclization.2024

 

Ms. Yufang Ma-Pharmaceutical Chemistry-Best Researcher Award

Ms. Yufang Ma-Pharmaceutical Chemistry-Best Researcher Award

Wuhan University - China

Author Profile

Early Academic Pursuits

Ms. Yufang Ma's academic journey began with a fervent interest in the biomedical sciences. She completed her undergraduate studies with a focus on pharmacology, where she developed a strong foundation in understanding drug interactions and biological systems. Her early research interests centered around natural compounds, particularly flavonoids, which are known for their diverse pharmacological properties. This interest led her to delve deeper into the conformational relationships of these compounds, exploring how their structures influence their biological activities. Her dedication to her studies was reflected in her academic excellence and active participation in various research initiatives.

Professional Endeavors

Following her undergraduate studies, Ms. Yufang Ma pursued a Master's degree at Wuhan University, one of the top institutions in China. Her professional endeavors have been marked by her commitment to advancing pharmacological research. At Wuhan University, she has been primarily engaged in studying the conformational relationships of flavonoids and their pharmacological effects. Her research aims to uncover the therapeutic potential of these natural compounds, particularly in the context of treating neurological disorders such as epilepsy. This work not only contributes to the scientific community's understanding of flavonoids but also has the potential to lead to the development of new, effective treatments for epilepsy.

Contributions and Research Focus

Ms. Yufang Ma's contributions to pharmacological research are centered on her in-depth studies of flavonoids. Her primary research focus involves investigating the conformational relationships of these compounds and how their structural variations impact their pharmacological properties. She is particularly interested in the therapeutic potential of flavonoids in treating epilepsy, a neurological disorder characterized by recurrent seizures. Through her research, she aims to identify specific flavonoids that can modulate neuronal activity and reduce seizure frequency. This focus on epilepsy research is a significant contribution to the field, as it addresses a critical need for new, effective treatments for this debilitating condition.

Accolades and Recognition

While Yufang Ma's work is ongoing, she has already garnered recognition for her contributions to pharmacological research. Her dedication to exploring the therapeutic potential of flavonoids has been acknowledged by her peers and mentors at Wuhan University. Although she has not yet published extensively or secured patents, her research on epilepsy is paving the way for significant advancements in the field. The recognition she has received serves as a testament to her potential to make impactful contributions to pharmacology and therapeutics.

Impact and Influence

The impact of Yufang Ma's research extends beyond the academic community. Her work on flavonoids and epilepsy has the potential to influence the development of new pharmacological treatments. By identifying specific flavonoids with anticonvulsant properties, her research could lead to the creation of novel therapies that offer better efficacy and fewer side effects compared to existing treatments. This potential impact highlights the broader significance of her work in improving patient outcomes and enhancing the quality of life for individuals with epilepsy.

Legacy and Future Contributions

Ms. Yufang Ma's legacy in pharmacological research is still in the making, but her ongoing work promises to leave a lasting impact on the field. As she continues to explore the therapeutic potential of flavonoids, her findings could pave the way for new treatment paradigms in epilepsy and other neurological disorders. Her future contributions are likely to extend beyond research, potentially influencing clinical practices and drug development strategies. With her dedication and innovative approach, Ms. Yufang Ma is poised to become a leading figure in pharmacology, contributing to the advancement of science and the improvement of human health.

Notable Publication

Apigenin analogs as α-glucosidase inhibitors with antidiabetic activity, 2024.

Diosmetin Ameliorates HFD-induced Cognitive Impairments via Inhibiting Metabolic Disorders, Mitochondrial Dysfunction and Neuroinflammation in Male SD Rats, 2024